Startseite

Cefamandole Nafate

Cefamandole Nafate

Spezifikationen

42540-40-9CAS-Nummer
255-877-4EG-Nummer
sodium (6R,7R)-7-[[(2R)-2-formyloxy-2-phenylacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylateIUPAC-Name
C19H17N6NaO6S2Chemische Formel
512.5 g/molMolekulargewicht
cefamandole nafate; 42540-40-9; Cephamandole nafate; Cefamandol nafato; Bergacef; Cedol; Mandol; Mandolsan; Cefam; Cefamandole Nafate sodium; O-Formylcefamandole sodium; Sodium O-formylcefamandole; DTXSID2022751; Lilly 106223; 8HDO7941DO; NSC-299588; CHEBI:3481; DTXCID502751; RefChem:57266; NSC299588; Cemandil Sodium; Kefadol; Mandokef; MFCD00864877; Sodium (6R,7R)-7-(R)-mandelamido-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate formate (ester); Cefamandole formate sodium salt; Cefaseptolo; Lampomandol; Neocefal; Pavecef; Cefamandole nafate [USAN]; Cefamandole (nafate); Sodium (6R,7R)-7-(R)-mandelamido-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate formate (ester); sodium (6R,7R)-7-[(2R)-2-(formyloxy)-2-phenylacetamido]-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; sodium (6R,7R)-7-{[(2R)-2-(formyloxy)-2-phenylacetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; NCGC00183035-01; Cefamandol nafato [Spanish]; UNII-8HDO7941DO; Kefandol; EINECS 255-877-4; Mandol (TN); NSC 299588; Cefamandole formate sodium;Cephamandole nafate; Cefamandole nafate CRS; Cefamandole nafate [USAN:USP:INN:BAN]; sodium;(6R,7R)-7-[[(2R)-2-formyloxy-2-phenylacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; Cefamandole nafate, 97%; Cefamandole nafate (USP); CHEMBL1618; SCHEMBL181311; orb1221300; orb1302386; CEFAMANDOLE NAFATE [MI]; CEFAMANDOLE NAFATE [VANDF]; CEFAMANDOLE NAFATE [MART.]; CEFAMANDOLE NAFATE [USP-RS]; CEFAMANDOLE NAFATE [WHO-DD]; HY-B1166; MSK12031; Tox21_113487; AKOS015895550; AKOS015961133; AC-1642; CCG-269787; CS-4768; EBC-101066; FC19846; GS-3575; CEFAMANDOLE NAFATE [ORANGE BOOK]; CEFAMANDOLE NAFATE [EP MONOGRAPH]; CEFAMANDOLE NAFATE [USP IMPURITY]; AS-12360; CAS-42540-40-9; NS00089630; T4992; C08102; D00909; EN300-25025857; Q27106102; Z3041521791; (6R,7R)-7-[[(2R)-2-(Formyloxy)-2-phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct -2-ene-2-carboxylic acid sodium; 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-(((FORMYLOXY)PHENYLACETYL)AMINO)-3-(((1-METHYL-1H-TETRAZOL-5-YL)THIO)METHYL)-8-OXO-, MONOSODIUM SALT, (6R-(6.ALPHA.,7.BETA.(R*))); 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((formyloxy)phenylacetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt, (6R-(6alpha,7beta(R*)))-; sodium (6R,7R)-7-((R)-2-(formyloxy)-2-phenylacetamido)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; sodium (6R,7R)-7-{[(2R)-2-(formyloxy)-2-phenylacetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; Sodium (6R-(6alpha,7beta(R*)))-7-(((formyloxy)phenylacetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate; sodium 7beta-[(2R)-2-(formyloxy)-2-phenylacetamido]-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}ceph-3-em-4-carboxylate; SODIUM(6R,7R)-7-(R)-MANDELAMIDO-3-(((1-METHYL-1H-TETRAZOL-5-YL)THIO)METHYL)-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLATE FORMATE(ESTER); sodium;(6R7R)-7-[[(2R)-2-formyloxy-2-phenylacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylateSynonyme